spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

6th Annual Single Cell Analysis Congress

Oxford Global Events - Single Cell

8-9 November 2018
London, UK

Oxford Global is proud to present its 6th Annual Single Cell Analysis Congress taking place on 8-9 November 2018 in London.  Part of the Genomics & Synthetic Biology Series UK, the congress will bring together over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.

Going into its 6th year, our Single Cell Analysis Congress will feature Over 45 case studies and presentations focused on the developments in Single Cell Analysis, Drug Discovery and Therapeutic Development and Clinical Development.

Join Europeís most successful Genomics Congress and take part in four events across the two days:

  • 10th Annual Next Generation Sequencing & Clinical Diagnostics Congress
  • 6th Annual Single Cell Analysis Congress
  • 4th Annual Genome Editing Congress
  • Synthetic Biology Congress

View the Agenda here>>https://bit.ly/2wFy4ej

For further information, prices & group discounts please contact d.dalby@oxfordglobal.co.uk

 

phone +44 (0)1865 248455
email d.dalby@oxfordglobal.co.uk
web https://bit.ly/2wJJRsc
email London
 
Print this page
Send to a friend
   
spacer
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: itís where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on todayís hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

White Papers

News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Companyís novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement